(Q33780253)

English

Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

20

object named as

John C Byrd

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

7

object named as

Kristie A Blum

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Leslie A Andritsos

2

object named as

Leslie Andritsos

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

8

object named as

William Blum

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

14

object named as

David Jarjoura

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Chelsey A Raymond

10

object named as

Chelsey A Raymond

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

12

object named as

Amy Lehman

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Natarajan Muthusamy

18

object named as

Natarajan Muthusamy

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Rosa Lapalombella

1

object named as

Rosa Lapalombella

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

9

object named as

Asha Ramanunni

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Shih-Ching Chen

15

object named as

Ching-Shih Chen

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Christoph Rader

17

object named as

Christoph Rader

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

Qing Liu

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Sarah E May

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Rebekah Browning

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Lan V Pham

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Lisa L Smith

11

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Xiaokui Mo

13

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Richard Ford

16

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Amy J Johnson

19

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

24 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

115

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

2619-2629

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

A phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

Post-transcriptional regulation in lymphocytes: the case of CD154

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

Stem cell transplantation in chronic lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

Lenalidomide down-regulates the CD20 antigen and antagonizes direct and antibody-dependent cellular cytotoxicity of rituximab on primary chronic lymphocytic leukemia cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

Higher doses of lenalidomide are associated with unacceptable toxicity including life-threatening tumor flare in patients with chronic lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

Management of infectious complications in patients with chronic lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

Immunomodulating drugs for chronic lymphocytic leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

CD154 induces p73 to overcome the resistance to apoptosis of chronic lymphocytic leukemia cells lacking functional p53.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

Immunomodulatory drug CC-5013 or CC-4047 and rituximab enhance antitumor activity in a severe combined immunodeficient mouse lymphoma model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

Efficacy of lenalidomide in myelodysplastic syndromes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

Chromatin immunoprecipitation assay

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

A one-step procedure for biotinylation and chemical cross-linking of lymphocyte surface and intracellular membrane-associated molecules

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

The CD40 ligand expressed by human B cells costimulates B cell responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

Crossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

Serum immunoglobulins in B-chronic lymphocytic leukemia. Natural history and prognostic significance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

T cell helper defect in patients with chronic lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

4 July 2018

lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

30 October 2018

Fas-ligand (CD178) and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

30 October 2018

Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

30 October 2018

Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: implications for clinical trials in this patient population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

30 October 2018

Influenza virus vaccination and booster in B-cell chronic lymphocytic leukaemia patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

30 October 2018

Acquired CD40-ligand deficiency in chronic lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2852364

30 October 2018

HETEs enhance IL-1-mediated COX-2 expression via augmentation of message stability in human colonic myofibroblasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/19965642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules

1 reference

https://pubmed.ncbi.nlm.nih.gov/19965642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of autologous mixed lymphocyte reaction in patients with chronic lymphocytic leukemia: evidence for autoreactive T-cell dysfunction not correlated with phenotype, karyotype, or clinical status

1 reference

https://pubmed.ncbi.nlm.nih.gov/19965642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity

1 reference

https://pubmed.ncbi.nlm.nih.gov/19965642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of CD154 (CD40 ligand) mRNA stability during T cell activation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19965642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to vaccination against different types of antigens in patients with chronic lymphocytic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19965642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum immunoglobulins and lymphocyte subsets in chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19965642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vaccine therapy and chronic lymphocytic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19965642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved vaccination response during ranitidine treatment, and increased plasma histamine concentrations, in patients with B cell chronic lymphocytic leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19965642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of ranitidine on antibody responses to polysaccharide vaccines in patients with B-cell chronic lymphocytic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19965642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoglobulin replacement therapy by self-infusion at home

1 reference

https://pubmed.ncbi.nlm.nih.gov/19965642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody response to 7-valent conjugated pneumococcal vaccine in patients with chronic lymphocytic leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19965642

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2009-09-242438

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33780253&oldid=1932757156"